21May
16May
How Wasabi Is Taking On Amazon in the Cloud
Wasabi Technologies, Inc. Chief Executive Officer David Friend discusses how the company is taking on Amazon.com in cloud storage. He speaks with Bloomberg's Carol Massar on "Bloomberg Technology." Read more >>
16May
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company focused on treating inflammatory and fibrotic diseases by targeting the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at two upcoming investor conferences in May. Read more >>
16May
How Wasabi Is Taking On Amazon in the Cloud
Wasabi Technologies, Inc. Chief Executive Officer David Friend discusses how the company is taking on Amazon.com in cloud storage. He speaks with Bloomberg's Carol Massar on "Bloomberg Technology." Read more >>
14May
Aircuity Installation in Georgetown University Science Building Saves Energy
Knowing the enormous utility costs associated with running a science facility, Georgetown’s Energy and Utilities department invited Aircuity to evaluate how its platform could help reduce energy consumption while improving lab safety. Read more >>
12May
Kid Subscription Boxes Are Trending Right Now—For a Few Good Reasons
With Toys ‘R’ Us shutting down their 735 stores in 2018, millennial parents have been finding new ways to encourage playtime for their children (besides the endless Amazon Prime deliveries!)—and many have looked no further than to kid subscription boxes. Read more >>
09May
Retail When Subscription Merchants Innovate With Plan Features
To make life easier for their customers, many businesses are adopting the subscription business model. From consumer goods and hardware to eCommerce and internet of things (IoT), innovators are allowing shoppers to have products and offerings regularly delivered to them. From Perennial to Green Piñata Toys, eCommerce innovators are tapping into the subscription business model to deliver goods to customers on a recurring basis. Read more >>
03May
TetraGenetics Appoints Alison Taunton-Rigby, Ellen Baron and Daniel Grau to its Board of Directors
TetraGenetics, a biopharmaceutical company developing novel antibody therapeutics for ion-channel mediated disorders, announced today the addition of three new board members: Alison Taunton-Rigby Ph.D., OBE, Ellen Baron Ph.D. and Daniel Grau M. Phil. Read more >>
03May
Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
Corbus Pharmaceuticals Holdings, Inc. today announced the completion of subject enrollment in RESOLVE-1, a Phase 3 study assessing the efficacy and safety of lenabasum for the treatment of systemic sclerosis (SSc). The Company expects to report topline results from this study in the summer of 2020. These data are anticipated to support an initial marketing application for lenabasum. Read more >>
02May